These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17167125)

  • 1. Disclosure of HIV status and sexual orientation independently predicts increased absolute CD4 cell counts over time for psychiatric patients.
    Strachan ED; Bennett WR; Russo J; Roy-Byrne PP
    Psychosom Med; 2007 Jan; 69(1):74-80. PubMed ID: 17167125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression.
    Nnoruka EN; Chukwuka JC; Anisuiba B
    Int J Dermatol; 2007 Oct; 46 Suppl 2():14-8. PubMed ID: 17958624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
    Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
    Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative analysis of partner selection, HIV serostatus disclosure, and sexual behaviors among HIV-positive urban men.
    Relf MV; Bishop TL; Lachat MF; Schiavone DB; Pawlowski L; Bialko MF; Boozer DL; Dekker D
    AIDS Educ Prev; 2009 Jun; 21(3):280-97. PubMed ID: 19519241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and correlates of HIV serostatus disclosure.
    O'Brien ME; Richardson-Alston G; Ayoub M; Magnus M; Peterman TA; Kissinger P
    Sex Transm Dis; 2003 Sep; 30(9):731-5. PubMed ID: 12972799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
    Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?
    Bongiovanni M; Gori A; Lepri AC; Antinori A; de Luca A; Pagano G; Chiodera A; Puoti M; Monforte Ad;
    Clin Infect Dis; 2007 Sep; 45(5):650-3. PubMed ID: 17683003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts.
    Goh BK; Chan RK; Sen P; Theng CT; Tan HH; Wu YJ; Paton NI
    Int J Dermatol; 2007 Jul; 46(7):695-9. PubMed ID: 17614796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients.
    McGovern BH; Golan Y; Lopez M; Pratt D; Lawton A; Moore G; Epstein M; Knox TA
    Clin Infect Dis; 2007 Feb; 44(3):431-7. PubMed ID: 17205454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.
    Huttner AC; Kaufmann GR; Battegay M; Weber R; Opravil M
    AIDS; 2007 May; 21(8):939-46. PubMed ID: 17457087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should absolute lymphocyte count be used as a surrogate marker for CD4+ count in patients with HIV/AIDS?
    Jibrin YB; Yusuph H; Garbati MA; Gashau W; Abja UM
    Afr J Med Med Sci; 2006 Mar; 35(1):9-13. PubMed ID: 17209321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and immune activation in patients with HIV-infection.
    Schroecksnadel K; Sarcletti M; Winkler C; Mumelter B; Weiss G; Fuchs D; Kemmler G; Zangerle R
    Brain Behav Immun; 2008 Aug; 22(6):881-9. PubMed ID: 18261883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006.
    Keruly JC; Moore RD
    Clin Infect Dis; 2007 Nov; 45(10):1369-74. PubMed ID: 17968837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type C coping, alexithymia, and heart rate reactivity are associated independently and differentially with specific immune mechanisms linked to HIV progression.
    Temoshok LR; Waldstein SR; Wald RL; Garzino-Demo A; Synowski SJ; Sun L; Wiley JA
    Brain Behav Immun; 2008 Jul; 22(5):781-92. PubMed ID: 18346864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreasing CD4+ T-cell count during suppressed or low-level viraemia in patients with HIV infection.
    Anderson AM; Kosinski AS; Bartlett JA
    Antivir Ther; 2007; 12(7):1041-8. PubMed ID: 18018762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between psychological distress and T lymphocyte in HIV/AIDS patients].
    Lu SH; Tang XP; Deng XL; Chen WL; Hu RX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):23-5. PubMed ID: 19799009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disclosure of HIV antibody status: behavioral and mental health correlates.
    Ostrow DG; Joseph JG; Kessler R; Soucy J; Tal M; Eller M; Chmiel J; Phair JP
    AIDS Educ Prev; 1989; 1(1):1-11. PubMed ID: 2641214
    [No Abstract]   [Full Text] [Related]  

  • 20. Processes and outcomes of HIV serostatus disclosure to sexual partners among people living with HIV in Uganda.
    King R; Katuntu D; Lifshay J; Packel L; Batamwita R; Nakayiwa S; Abang B; Babirye F; Lindkvist P; Johansson E; Mermin J; Bunnell R
    AIDS Behav; 2008 Mar; 12(2):232-43. PubMed ID: 17828450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.